NextAR RSA Platform— 510(k) K210153

Substantially Equivalent

Medacta International S.A.

FDA 510(k) clearance K210153 for NextAR RSA Platform, Substantially Equivalent on 2021-05-12. Applicant: Medacta International S.A..

Clearance details

Applicant: Medacta International S.A.
Product code: Code SBF
Advisory panel: Neurology
Date received: 2021-01-21
Decision date: 2021-05-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Castel San Pietro (Ch), CH

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.